戻る Agenda
Optimizing Cell and Gene Therapy Clinical Trial Virtualization and Remote Monitoring in the Time of COVID-19
Session Chair(s)
Monica Ravindra Shah, DrMed, FACC
Therapeutic Science and Strategy Unit Vice President and Head, CAGT COE
IQVIA, United States
Using virtual-hybrid and remote solutions, we describe an innovative model for monitoring and executing cell and gene therapy clinical trials during COVID-19. These approaches serve as an instructive path forward for the future of these therapies.
Learning Objective : Describe evolving strategies with innovative solutions for delivering cell and gene therapy trials during COVID-19; Discuss specific areas of trial risk, patient safety, data quality, and how virtual and remote activities are being successfully deployed; Analyze metrics to date and how these support a paradigm shift in the operation of these trials.
Speaker(s)
Industry Update
Chris A Learn, PhD, PMP
Parexel, United States
Vice President, Cell and Gene Therapy Center of Excellence
Industry Update
Erin Finot, MBA, MS
IQVIA, United States
Vice President, Immuno-Oncology
Industry Update
Molly Mjolsness, MBA
Be The Match Biotherapies, United States
Senior Client Delivery Manager